59307-9 |
Metaxalone |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Metaxalone [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
0.025 mcg/mL |
|
|
|
|
|
DRUG/TOX |
|
59307-9 |
|
|
|
|
Both |
|
|
|
0 |
Metaxalone Bld-mCnc |
|
|
|
N |
|
Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Skelaxin; WB; Whole blood |
2.7 |
2.32 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
59308-7 |
Metaxalone |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Metaxalone [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
0.025 mcg/mL |
|
|
|
|
|
DRUG/TOX |
|
59308-7 |
|
|
|
|
Both |
|
|
|
0 |
Metaxalone SerPl-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Skelaxin; SR |
2.7 |
2.32 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
59309-5 |
Metaxalone |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Metaxalone [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
0.025 mcg/mL |
|
|
|
|
|
DRUG/TOX |
|
59309-5 |
|
|
|
|
Both |
|
|
|
0 |
Metaxalone Ur-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Skelaxin; UA; UR; Urn |
2.7 |
2.32 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
5931-1 |
Trichophyton reaction wheal^3D post 50 ug trichophyton ID |
Diam |
Skin |
Pt |
Qn |
|
|
ACTIVE |
Trichophyton reaction wheal [Diameter] --3 days post 50 ug trichophyton intradermal |
|
MIN |
DefinitionDescription |
|
|
mm |
|
|
|
|
|
|
CHALSKIN |
|
5931-1 |
|
|
|
|
Observation |
|
|
|
0 |
Wheal 3D p 50ug Trichophyt Diam |
|
|
|
Y |
|
3D p 50ug Trichophyt; After; Dermatologic; Diameter; Epidermis; Identifier; Integument; Intradermal; mcg; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; React; Rx wheal; Rxn; Skin test; SKIN TESTS; Skn |
2.42 |
1.0c |
|
|
|
|
|
|
|
mm |
|
|
|
0 |
59310-3 |
Milnacipran |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Milnacipran [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
10 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59310-3 |
|
|
|
|
Both |
|
|
|
0 |
Milnacipran Bld-mCnc |
|
|
|
N |
|
Blood; DRUG/TOXICOLOGY; Drugs; Ixel; Level; Mass concentration; Mildalcipran; Point in time; QNT; Quan; Quant; Quantitative; Random; Salvella; Toledomin; WB; Whole blood |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59311-1 |
Milnacipran |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Milnacipran [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
10 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59311-1 |
|
|
|
|
Both |
|
|
|
0 |
Milnacipran SerPl-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Ixel; Level; Mass concentration; Mildalcipran; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Salvella; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Toledomin |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59312-9 |
Milnacipran |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Milnacipran [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
10 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59312-9 |
|
|
|
|
Both |
|
|
|
0 |
Milnacipran Ur-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Ixel; Level; Mass concentration; Mildalcipran; Point in time; QNT; Quan; Quant; Quantitative; Random; Salvella; Toledomin; UA; UR; Urn |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59313-7 |
Ramelteon M-II |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Ramelteon M-II [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
5 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59313-7 |
|
|
|
|
Both |
|
|
|
0 |
Ramelteon M-II Bld-mCnc |
|
|
|
N |
|
2; Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Ramelton metabolite; Random; Rozerem; WB; Whole blood |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59314-5 |
Ramelteon |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Ramelteon [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
1 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59314-5 |
|
|
|
|
Both |
|
|
|
0 |
Ramelteon Bld-mCnc |
|
|
|
N |
|
Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rozerem; WB; Whole blood |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59315-2 |
Ramelteon M-II |
MCnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
Ramelteon M-II [Mass/volume] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
5 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59315-2 |
|
|
|
|
Both |
|
|
|
0 |
Ramelteon M-II Fld-mCnc |
|
|
|
N |
|
2; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Ramelton metabolite; Random; Rozerem |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59316-0 |
Ramelteon |
MCnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
Ramelteon [Mass/volume] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
1 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59316-0 |
|
|
|
|
Both |
|
|
|
0 |
Ramelteon Fld-mCnc |
|
|
|
N |
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rozerem |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59317-8 |
Ramelteon M-II |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Ramelteon M-II [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
5 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59317-8 |
|
|
|
|
Both |
|
|
|
0 |
Ramelteon M-II SerPl-mCnc |
|
|
|
N |
|
2; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Ramelton metabolite; Random; Rozerem; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59318-6 |
Ramelteon |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Ramelteon [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
1 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59318-6 |
|
|
|
|
Both |
|
|
|
0 |
Ramelteon SerPl-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Rozerem; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59319-4 |
Ramelteon M-II |
MCnt |
Tiss |
Pt |
Qn |
|
|
ACTIVE |
Ramelteon M-II [Mass/mass] in Tissue |
|
MIN |
DefinitionDescription |
|
|
ng/g |
5 ng/g |
|
|
|
|
|
DRUG/TOX |
|
59319-4 |
|
|
|
|
Both |
|
|
|
0 |
Ramelteon M-II Tiss-mCnt |
|
|
|
N |
|
2; DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Ramelton metabolite; Random; Rozerem; Tissue; Tissue, unspecified |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/g |
|
|
Changed Property from 'MCnc' it fit the current LOINC model. |
0 |
5932-9 |
Cholesterol |
PrThr |
Bld |
Pt |
SemiQn |
Test strip |
|
ACTIVE |
Cholesterol [Presence] in Blood by Test strip |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
5932-9 |
|
Test strip |
|
|
Both |
|
|
|
0 |
Cholest Bld Strip |
|
|
|
|
|
Blood; Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Dip stick; Dipstick; Heart Disease; Lipid; Point in time; PR; Random; SmQn; WB; Whole blood |
2.75 |
1.0d |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
59320-2 |
Ramelteon |
MCnt |
Tiss |
Pt |
Qn |
|
|
ACTIVE |
Ramelteon [Mass/mass] in Tissue |
|
MIN |
DefinitionDescription |
|
|
ng/g |
1 ng/g |
|
|
|
|
|
DRUG/TOX |
|
59320-2 |
|
|
|
|
Both |
|
|
|
0 |
Ramelteon Tiss-mCnt |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Rozerem; Tissue; Tissue, unspecified |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/g |
|
|
Changed Property from 'MCnc' it fit the current LOINC model. |
0 |
59321-0 |
Ramelteon M-II |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Ramelteon M-II [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
5 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59321-0 |
|
|
|
|
Both |
|
|
|
0 |
Ramelteon M-II Ur-mCnc |
|
|
|
N |
|
2; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Ramelton metabolite; Random; Rozerem; UA; UR; Urn |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59322-8 |
Ramelteon |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Ramelteon [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
1 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59322-8 |
|
|
|
|
Both |
|
|
|
0 |
Ramelteon Ur-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Rozerem; UA; UR; Urn |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59323-6 |
Rufinamide |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Rufinamide [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
0.5 mcg/mL |
|
|
|
|
|
DRUG/TOX |
|
59323-6 |
|
|
|
|
Both |
|
|
|
0 |
Rufinamide SerPl-mCnc |
|
|
|
N |
|
Banzel; DRUG/TOXICOLOGY; Drugs; Lennox-Gastaut syndrome; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.32 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
59324-4 |
Salvinorin A |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Salvinorin A [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
1 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59324-4 |
|
|
|
|
Both |
|
|
|
0 |
Salvinorin A Bld-mCnc |
|
|
|
N |
|
Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Salvia; WB; Whole blood |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59325-1 |
Salvinorin B |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Salvinorin B [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
1 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59325-1 |
|
|
|
|
Both |
|
|
|
0 |
Salvinorin B Bld-mCnc |
|
|
|
N |
|
2-Methoxymethyl Salvinorin B; Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Salvia; WB; Whole blood |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59326-9 |
Salvinorin A |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Salvinorin A [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
1 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59326-9 |
|
|
|
|
Both |
|
|
|
0 |
Salvinorin A SerPl-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Salvia; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59327-7 |
Salvinorin B |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Salvinorin B [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
1 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59327-7 |
|
|
|
|
Both |
|
|
|
0 |
Salvinorin B SerPl-mCnc |
|
|
|
N |
|
2-Methoxymethyl Salvinorin B; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Salvia; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59328-5 |
Salvinorin A |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Salvinorin A [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
1 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59328-5 |
|
|
|
|
Both |
|
|
|
0 |
Salvinorin A Ur-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Salvia; UA; UR; Urn |
2.73 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
59329-3 |
Salvinorin B |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Salvinorin B [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
1 ng/mL |
|
|
|
|
|
DRUG/TOX |
|
59329-3 |
|
|
|
|
Both |
|
|
|
0 |
Salvinorin B Ur-mCnc |
|
|
|
N |
|
2-Methoxymethyl Salvinorin B; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Salvia; UA; UR; Urn |
2.73 |
2.32 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |